New and improved bioink to enhance 3D bioprinted skeletal muscle constructs

An advancement in 3D bioprinting of native-like skeletal muscle tissues has been made by scientists at the Terasaki Institute for Biomedical Innovation (TIBI). The key to the TIBI scientists’ approach lies in their specially formulated bioink, which contains microparticles engineered for sustained delivery of insulin-like growth factor-1 (IGF-1).

This post was originally published on this site

Skip The Dishes Referral Code